USP with new Chapter on Supplier Qualification and Guidance for associated Risk Assessments
Recommendation

20-22 October 2026
Initial and Continuous Professional Training for GMP-Auditors
As indicated earlier this year, the U.S. Pharmacopeia USP intends to publish a new informational chapter on Supplier Qualification. It was proposed by the General Chapters-Packaging and Distribution Expert Committee. The chapter will get the number <1083>, the former number of the proposed chapter on Good Distribution Practice GDP, which was dismissed.
The aim is to "discuss the importance of supplier qualification and the application of a quality risk-based approach to select, assess, approve, and monitor suppliers of materials and services". Core of the proposal is a six-step process:
- Preparation
- Identification and selection
- Evaluation and acceptance
- Performance monitoring
- Disqualification
- Conditional approval of an existing supplier
For each of these steps, expectations and the rationale of tasks are provided. It is also pointed out that quality risk-based approaches should be used and implemented throughout the process steps. A separate table lists examples of various items that can be considered as part of such a risk assessment. Even though the USP has no direct force of law, certainly not in Europe, interesting pointers for use in risk-based supplier qualification programmes can be found here.
The draft can be viewed in the Pharmacopeial Forum. (Please note: a one-time registration is required to access the Pharmacopeial Forum.)
![]() | Live Online Training: Efficient Supplier Qualification 30/31 March 2022 |
Related GMP News
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?



